LUIS
CAMINAL MONTERO
Investigador/a
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (11)
2023
-
Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?
International Journal of Molecular Sciences, Vol. 24, Núm. 17
-
Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients
Medicina (Kaunas, Lithuania), Vol. 59, Núm. 8
-
Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism
Annals of the Rheumatic Diseases, Vol. 82, Núm. 12, pp. 1594-1605
2022
-
IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms
Journal of Clinical Medicine, Vol. 11, Núm. 19
2021
-
Author Correction: BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis (Scientific Reports, (2021), 11, 1, (11510), 10.1038/s41598-021-91055-z)
Scientific Reports
-
BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis
Scientific Reports, Vol. 11, Núm. 1
-
Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis
Scientific Reports, Vol. 11, Núm. 1
2017
-
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis
American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74
-
Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort
Autoimmunity Reviews, Vol. 16, Núm. 8, pp. 796-802
2014
-
Influence of the IL17A locus in giant cell arteritis susceptibility
Annals of the Rheumatic Diseases, Vol. 73, Núm. 9, pp. 1742-1745
2007
-
Prevalencia de enfermedad arterial periférica estimada mediante el índice tobillo-brazo en pacientes con síndrome metabólico. Estudio MERITO I
Revista Clinica Espanola, Vol. 207, Núm. 5, pp. 228-233